<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
CRIS
Curis
$
()


  • Two new option listings and option delistings on March 25th

    3/25/2024 - 08:31am
  • Truist biotech analysts hold an analyst/industry conference call

    2/26/2024 - 11:45am
  • Truist biotech analysts hold an analyst/industry conference call

    2/26/2024 - 04:55am
  • Truist biotech analysts hold an analyst/industry conference call

    2/21/2024 - 12:10pm
  • Curis price target lowered by $25 at H.C. Wainwright, here's why

    2/9/2024 - 06:12am
  • Curis files $300M common stock offering

    2/8/2024 - 16:29pm
  • Curis sees cash, cash equivalents and investments sufficient into 2025

    2/8/2024 - 08:08am
  • Curis reports Q4 EPS ($2.03), consensus ($2.11)

    2/8/2024 - 08:08am
  • Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call

    12/14/2023 - 10:50am
  • Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call

    12/14/2023 - 05:55am
  • Curis' licensed emavusertib shows efficacy in lymphoma trial

    12/12/2023 - 08:04am
  • Curis presented data from the TakeAim Leukemia study at 2023 ASH conference

    12/11/2023 - 08:10am
  • Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call

    12/7/2023 - 10:15am
  • Curis signs agreement for emavusertib/pembrolizumab combination melanoma study

    12/5/2023 - 08:03am
  • Biotech Alert: Searches spiking for these stocks today

    11/20/2023 - 10:55am
dynamic_feed Breaking News